Enterotoxigenic E. coli (ETEC)

Escherichia coli (E. coli) is a type of bacteria that normally lives in the intestines of humans and animals. Most strains of E. coli are harmless and even beneficial for the digestion and absorption of nutrients. However, some strains of E. coli can cause infections and diseases in humans, such as urinary tract infections, sepsis, meningitis, and diarrhea.

Enterotoxigenic E. coli (ETEC) is one of the most common causes of bacterial diarrhea in developing countries and among travelers to these regions. ETEC is responsible for an estimated 840 million cases and 300,000 to 500,000 deaths annually, mainly in children under five years old. ETEC can also cause diarrhea in animals, such as pigs, calves, and lambs.

ETEC is characterized by the production of two types of toxins: heat-labile toxin (LT) and heat-stable toxin (ST). These toxins act on the intestinal cells and stimulate the secretion of fluids and electrolytes, resulting in watery diarrhea. ETEC strains may express LT only, ST only, or both LT and ST.

ETEC is transmitted by consuming food or water contaminated with animal or human feces that contain the bacteria. The infection usually occurs after ingesting a large number of bacteria (more than 10 million), which indicates poor sanitation and hygiene conditions. Person-to-person transmission is rare.

ETEC can be identified by detecting the LT and/or ST toxins in stool samples or cultures using immunoassays or PCR methods. ETEC strains belong to various serotypes based on their surface antigens (O and H antigens), but some serotypes are more frequently associated with human disease than others, such as O6, O8, O15, O25, O27, O153, and O159.

ETEC infection usually causes mild to moderate symptoms that last for 3 to 4 days. The main symptom is watery diarrhea, which may be accompanied by abdominal cramps, nausea, vomiting, fever, and dehydration. In some cases, especially in children, elderly people, and immunocompromised individuals, the infection can lead to severe dehydration, electrolyte imbalance, malnutrition, and death.

ETEC infection can be treated with supportive measures such as oral rehydration therapy (ORT) or intravenous fluids to prevent or correct dehydration. Antibiotics may be used in some cases to shorten the duration of symptoms and reduce bacterial shedding. However, antibiotic resistance among ETEC strains is a growing concern.

ETEC infection can be prevented by following safe food and water practices, such as boiling or treating water before drinking it; washing hands with soap before eating or preparing food; avoiding raw or undercooked foods; peeling fruits and vegetables; and using clean utensils and dishes. For travelers to high-risk areas, prophylactic antibiotics or vaccines may be considered, but their efficacy and availability are limited.

ETEC is a major public health problem that affects millions of people worldwide every year. It is a preventable disease that can be controlled by improving sanitation, hygiene, and access to safe water and food sources. It is also a target for vaccine development and research to reduce its burden and mortality.

Enterotoxigenic E. coli (ETEC) is one of the leading bacterial causes of diarrhea in the developing world, as well as the most common cause of travelers` diarrhea. It is estimated that each year, about 157,000 deaths occur, mostly in children, from ETEC infection.

The disease caused by ETEC is named Travelers diarrhea and Weanling diarrhea (infant diarrhea) in developing countries. Travelers diarrhea affects people who travel to areas with poor sanitation and hygiene, where they are exposed to contaminated food or water. Weanling diarrhea affects infants and young children who are weaned from breast milk and introduced to solid foods or formulas that may be contaminated with ETEC.

Both diseases are characterized by watery, non-bloody diarrhea and abdominal cramps. The symptoms usually develop 1-3 days after exposure and last for 3-4 days but may persist for longer in some cases. The severity of the disease depends on the amount and type of enterotoxins produced by ETEC, as well as the host`s immune status and intestinal physiology.

ETEC infection can lead to dehydration, electrolyte imbalance, and malnutrition, especially in children and the elderly. In some cases, ETEC infection can also cause systemic complications such as sepsis, hemolytic uremic syndrome, or neurological disorders.

ETEC is transmitted by food or water that has been contaminated with animal or human feces. This can happen when food handlers do not wash their hands properly after using the toilet, when raw foods are washed with contaminated water, or when sewage leaks into drinking water sources. ETEC can survive for several days in water and on moist surfaces.

The Person-to-person spread of ETEC does not occur, as a large number of bacteria (about 10 million) are needed to cause infection. Therefore, direct contact with an infected person`s stool is unlikely to transmit the disease. However, indirect contact through shared utensils, cups, or towels can still pose a risk if they are contaminated with fecal matter.

Travelers to developing countries are at a higher risk of acquiring ETEC infection, as they may encounter poor sanitation and hygiene conditions, unfamiliar foods, and different strains of bacteria. Children under five years old living in low-resource settings are also more vulnerable to ETEC infection, as they have less immunity and exposure to the bacteria.

To prevent ETEC infection, it is important to avoid or safely prepare foods and beverages that could be contaminated with the bacteria, such as raw fruits and vegetables, unpasteurized dairy products, street food, ice cubes, and tap water. It is also advisable to wash hands with soap and water frequently, especially before eating and after using the toilet.

ETEC strains cause diarrhea by producing two types of toxins: heat-stable (ST) and heat-labile (LT) enterotoxins. These toxins act on the cells lining the small intestine and disrupt the normal balance of fluid and electrolyte absorption and secretion, resulting in watery diarrhea.

ST and LT enterotoxins are encoded by plasmids that can be transferred between different ETEC strains. ETEC strains can produce either ST or LT enterotoxins or both. ST enterotoxins are more commonly associated with severe disease than LT enterotoxins.

ST enterotoxins are small peptides that bind to a specific receptor on the intestinal cells called guanylate cyclase C. This receptor normally regulates the levels of cyclic guanosine monophosphate (cGMP), a molecule that controls fluid and electrolyte transport across the cell membrane. When ST enterotoxins bind to this receptor, they activate it and cause an increase in cGMP levels, which leads to increased secretion of fluid and electrolytes into the intestinal lumen, as well as decreased absorption of fluid and electrolytes from the lumen. This causes a net loss of water and salts from the body, resulting in dehydration and diarrhea.

LT enterotoxins are larger proteins that consist of one A subunit and five B subunits. The B subunits bind to specific receptors on the intestinal cells called GM1 gangliosides, as well as other surface glycoproteins. The A subunit then enters the cell and interacts with a protein called Gs that regulates the levels of cyclic adenosine monophosphate (cAMP), another molecule that controls fluid and electrolyte transport across the cell membrane. When LT enterotoxins activate Gs, they cause an increase in cAMP levels, which leads to increased secretion of chloride ions into the intestinal lumen, as well as decreased absorption of sodium and chloride ions from the lumen. This also causes a net loss of water and salts from the body, resulting in dehydration and diarrhea.

In addition to stimulating fluid and electrolyte secretion, LT enterotoxins also trigger the release of prostaglandins and inflammatory cytokines from the intestinal cells. These molecules further enhance fluid loss and cause inflammation and pain in the gut.

Both ST and LT enterotoxins require bacterial attachment to the intestinal cells for their action. ETEC strains use special surface proteins called colonization factors (CF) to adhere to specific receptors on the intestinal cells. There are many types of CFs that vary in their antigenic properties and host specificity. Some CFs are more common in human ETEC strains than others. The presence of CFs also helps ETEC strains to resist clearance by the immune system and other factors in the gut.

The combination of CFs and enterotoxins determines the virulence and pathogenicity of ETEC strains. The severity of the disease depends on several factors, such as the dose of bacteria ingested, the type and amount of toxins produced, the susceptibility of the host, and the presence of other pathogens or conditions in the gut.

ETEC infection typically causes watery, non-bloody diarrhea and abdominal cramps. Some people may also experience nausea, vomiting, fatigue, loss of appetite, or low fever, but these are less common. The symptoms usually develop 1-3 days after exposure to the bacteria and last for 3-4 days, although some infections may take longer to resolve.

The main complication of ETEC infection is dehydration, which can result from the loss of fluids and electrolytes in the stool. Dehydration can cause symptoms such as dry mouth, thirst, reduced urine output, dizziness, or weakness. Severe dehydration can lead to shock, kidney failure, or death if not treated promptly. Dehydration is more likely to occur in children, elderly people, and those with underlying diseases or malnutrition, who are more vulnerable to the effects of fluid loss.

Another possible complication of ETEC infection is persistent diarrhea, which is defined as diarrhea lasting more than 14 days. Persistent diarrhea can cause weight loss, malabsorption, growth retardation, or impaired immunity in children. Persistent diarrhea may be caused by factors such as intestinal damage, coinfection with other pathogens, or immune dysfunction.

ETEC infection is usually self-limiting and does not cause serious complications in most healthy people. However, it can be a significant cause of morbidity and mortality in developing countries, where access to safe water, sanitation, and health care is limited.

The diagnosis of ETEC infection is based on the detection of the enterotoxins LT and/or ST in stool samples or bacterial cultures. There are different methods available for this purpose, such as immunoassays and PCR assays.

Immunoassays are tests that use antibodies to recognize and bind to specific antigens, such as enterotoxins. There are commercial immunoassays available for detecting ST in clinical specimens and cultures, such as enzyme-linked immunosorbent assays (ELISA) and latex agglutination tests. These tests are relatively simple, rapid, and inexpensive, but they may have low sensitivity and specificity, meaning that they may miss some cases or produce false positives.

PCR assays are tests that use DNA amplification techniques to detect the presence of specific genes, such as the genes encoding the enterotoxins. PCR assays can be used with clinical specimens or cultures, and they have high sensitivity and specificity, meaning that they can accurately identify ETEC cases. However, PCR assays require specialized equipment and trained personnel, and they may be more costly and time-consuming than immunoassays.

Both immunoassays and PCR assays have advantages and limitations, and the choice of the method depends on the availability of resources, the clinical setting, and the epidemiological context. In some cases, both methods may be used to confirm the diagnosis or to perform further characterization of the ETEC strains. For example, PCR assays can be used to determine the types of colonization factors and enterotoxins present in the ETEC strains, which can provide useful information for epidemiological surveillance and vaccine development.

Most cases of ETEC infection are mild and self-limiting, meaning that they resolve on their own without any specific treatment. However, some patients may experience severe dehydration, electrolyte imbalance, or complications that require medical attention. The main goals of treatment are to prevent or correct dehydration and to reduce the duration and severity of symptoms.

The most important treatment for ETEC infection is oral rehydration therapy (ORT), which involves drinking fluids that contain water, salt, and sugar to replace the losses from diarrhea. ORT can be given using commercially available packets of oral rehydration salts (ORS) that are mixed with clean water or using homemade solutions that follow a specific recipe. ORT should be started as soon as possible after the onset of diarrhea and continued until the stools are normal. ORT can prevent dehydration in most patients and can also reduce the need for hospitalization and intravenous fluids.

In addition to ORT, some patients may benefit from antibiotics to shorten the duration of diarrhea and reduce the risk of complications. Antibiotics are recommended for patients who have severe or persistent diarrhea, high fever, blood or mucus in the stools, signs of dehydration, or underlying medical conditions that increase the risk of complications. The choice of antibiotics depends on the local patterns of antibiotic resistance and the availability of drugs. Some commonly used antibiotics for ETEC infection are fluoroquinolones (such as ciprofloxacin or levofloxacin), azithromycin, rifampin, or doxycycline. Antibiotics should be taken for 3 to 5 days or as prescribed by a health care provider.

Other treatments that may help relieve some symptoms of ETEC infection include antidiarrheal agents and probiotics. Antidiarrheal agents such as loperamide or bismuth subsalicylate can reduce the frequency and volume of stools, but they should be used with caution and only under medical supervision, as they may worsen some complications or mask the signs of dehydration. Probiotics are live microorganisms that can restore the balance of the intestinal flora and may have some beneficial effects on diarrhea, but more research is needed to confirm their efficacy and safety for ETEC infection.

The following table summarizes the main treatment options for ETEC infection:

| Treatment | Indication | Examples | Notes |

| --- | --- | --- | --- |

| Oral rehydration therapy (ORT) | All patients with diarrhea | Oral rehydration salts (ORS), homemade solutions | Start as soon as possible and continue until stools are normal |

| Antibiotics | Severe or persistent diarrhea, high fever, blood or mucus in stools, signs of dehydration, underlying medical conditions | Fluoroquinolones, azithromycin, rifampin, doxycycline | Take for 3 to 5 days or as prescribed by a health care provider |

| Antidiarrheal agents | Mild to moderate diarrhea without complications | Loperamide, bismuth subsalicylate | Use with caution and only under medical supervision |

| Probiotics | Adjunctive therapy for diarrhea | Lactobacillus, Saccharomyces boulardii | More research is needed to confirm efficacy and safety |

The best way to prevent ETEC infection is to avoid exposure to contaminated food or water. This can be challenging in developing countries where sanitation and hygiene standards may be low. However, there are some general guidelines that travelers and residents can follow to reduce their risk of getting sick:

• Drink only bottled or boiled water or water that has been treated with chlorine or iodine. Avoid ice cubes, fountain drinks, and tap water.

• Eat only cooked food that is served hot and steaming. Avoid raw or undercooked meat, seafood, eggs, dairy products, fruits, and vegetables. Peel fruits and vegetables yourself before eating them.

• Wash your hands with soap and water before eating and after using the toilet. Use alcohol-based hand sanitizer if soap and water are not available.

• Avoid contact with animals and their feces. Do not swim in water that may be contaminated with sewage or animal waste.

• If you have diarrhea, drink plenty of fluids to prevent dehydration. Oral rehydration solutions (ORS) can help replace lost electrolytes and glucose. You can buy ORS packets at pharmacies or make your own by mixing 6 teaspoons of sugar and 1/2 teaspoon of salt in 1 liter of clean water.

• Seek medical attention if you have severe diarrhea (more than 6 loose stools in 24 hours), bloody stools, fever, dehydration, or signs of complications such as kidney failure or hemolytic uremic syndrome (HUS).

In addition to these measures, there are also some vaccines that can protect against ETEC infection. These vaccines are not widely available or recommended for routine use, but they may be useful for travelers who are at high risk of exposure or who have a history of severe or recurrent ETEC infection. Some examples of these vaccines are:

• Dukoral: This is an oral vaccine that contains inactivated cholera bacteria and recombinant cholera toxin B subunit. It provides protection against both cholera and ETEC infection by stimulating the production of antibodies in the intestinal mucosa. It requires two doses taken at least one week apart before travel and a booster dose every two years.

• ETEC Vaccine Patch: This is a transdermal patch that delivers heat-labile toxin (LT) antigens through the skin. It induces both systemic and mucosal immunity against ETEC infection by stimulating the production of antibodies in the blood and the intestinal mucosa. It requires one dose applied to the skin at least two weeks before travel and a booster dose every year.

• ACE527: This is an oral vaccine that contains three live attenuated ETEC strains that express different colonization factors (CFs) and heat-labile toxin (LT). It provides protection against ETEC infection by inducing both cellular and humoral immunity against multiple CFs and LT. It requires three doses taken on alternate days at least one week before travel.

These vaccines are not 100% effective and may have some side effects, such as abdominal pain, nausea, vomiting, diarrhea, fever, headache, and rash. Therefore, they should be used in conjunction with other preventive measures such as safe food and water practices and hand hygiene.

ETEC infection is a common cause of diarrhea in travelers and children in developing countries. It can be prevented by avoiding exposure to contaminated food or water, practicing good hygiene, drinking plenty of fluids, seeking medical attention if needed, and taking vaccines if available and indicated. By following these steps, you can reduce your risk of getting sick from ETEC and enjoy your travel or stay in developing countries.

We are Compiling this Section. Thanks for your understanding.